Center for
Psychedelic
Medicine
Exploring innovative treatments for patients struggling with addiction and other illnesses
The NYU Langone Health Center for Psychedelic Medicine performs health-focused research across the translational spectrum, from basic science to large-scale clinical trials.
Clinical research
Preclinical research
Clinical trial
Leadership
About us
News
Psychedelic Research Finds a Home in Academia
Learn from Ali McGhee, CPM Director Dr. Michael Bogenschutz, and others about how NYU and other academic institutions across the country are training the next generation of psychedelic researchers and clinicians, including through our Psychedelic Research Training Program and tri-institutional consortium with Yale University and Johns Hopkins University.
The legal psychedelic: Ketamine is a fast-acting treatment for depression (if you have the money)
Learn more about ketamine-assisted psychotherapy in this newsletter from Los Angeles Times reporter Laura Newberry. In this piece, the third in a series on psychedelic medicine, Dr. Kelley O’Donnell and others discuss how ketamine is used within and outside the context of psychedelic-assisted psychotherapy, and the various strengths and limitations of different treatment models.
Informed Consent in Psychedelic Therapy and Research: Why is it Complicated?
Watch the replay of this lively roundtable discussion from an event sponsored by Chacruna in partnership with the Project on Psychedelics Law and Regulation at the Petrie-Flom Center at Harvard Law School. The panel featured Dr. Kelley O’Donnell, Director of Clinical Training at the CPM, and colleagues as they discuss the topic of consent in psychedelic therapy.
Publications
Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD. Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress. Psychedelic Medicine.
Marini C, Northover NS, Gold ND, Rogers UK, O’Donnell KC, Tofighi B, Ross S, Bogenschutz B. (2023). A Systematic Approach to Standardizing Drinking Outcomes From Timeline Followback Data. Subst Abuse. Vol. 17 Pages 11782218231157558. doi: 10.1177/11782218231157558
Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ . (2023). Canalization and plasticity in psychopathology. Neuropharmacology. 2023 Mar 15;226:109398. doi: 10.1016/j.neuropharm.2022.109398.
Contact us
Interested in our research? Want to send feedback? Need details about our center? Let us know.